Alle berichten over deze gebeurtenis, automatisch gegroepeerd uit meerdere onafhankelijke bronnen.
Laatst bijgewerkt: 1 oktober 2026 om 16:20 · 6 artikelen · 1 bronnen
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.
Lees bij STAT News · 1 oktober 2026 om 15:22
Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.
Lees bij STAT News · 1 oktober 2026 om 14:47
In this edition of STAT Health Tech: A California insurer on how it may replicate Medicare's tech-enabled chronic-care experiment.
Lees bij STAT News · 1 oktober 2026 om 14:02
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Lees bij STAT News · 1 oktober 2026 om 10:30
Questions about the durability of an experimental Huntington's disease therapy matter to Wall Street. They matter less to those directly affected by the disease.
Lees bij STAT News · 1 oktober 2026 om 10:30
A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech gathering also known for deal-making.
Lees bij STAT News · 1 oktober 2026 om 08:30